Cancer
Malignant Lung Neoplasm
CI-CAN-00001140Explore in graph →
Top-level2,648 active trials51 approved drugs619 evidence items
- NCIt
- C7377
- ICD-10
- C33-C34
- DOID
- 1324
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001140Explore in graph →
Clinical trials
11,122 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,489)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02579564 | Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients | unknown | Phase 3 | 134 | Xinqiao Hospital of ChongqingOTHER | 0 | Oct 21, 2016 | clinicaltrials |
| NCT02938546 | 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study | unknown | Phase 3 | 200 | Shanghai Chest HospitalOTHER | 0 | Oct 21, 2016 |
| clinicaltrials |
| NCT02360761 | Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy(STEPS) | unknown | Phase 3 | 339 | Peking University People's HospitalOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02802540 | Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients | unknown | Phase 2 / Phase 3 | 78 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02883543 | First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation | unknown | Phase 3 | 330 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 0 | Aug 30, 2016 | clinicaltrials |
| NCT02879097 | Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC | unknown | Phase 3 | 200 | Cipla BioTec Pvt. Ltd.INDUSTRY | 0 | Aug 25, 2016 | clinicaltrials |
| NCT02875457 | Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin | unknown | Phase 3 | 100 | Third Military Medical UniversityOTHER | 0 | Aug 24, 2016 | clinicaltrials |
| NCT02859077 | EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism | unknown | Phase 3 | 100 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 0 | Aug 9, 2016 | clinicaltrials |
| NCT01460472 | Immunotherapy With Racotumomab in Advanced Lung Cancer | unknown | Phase 3 | 1,082 | Recombio SLINDUSTRY | 7 | Jul 29, 2016 | clinicaltrials |
| NCT01882621 | Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients | unknown | Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02780778 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT02772107 | Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 132 | Chinese PLA General HospitalOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013(CBPC) | unknown | Phase 3 | 164 | University Hospital, AngersOTHER_GOV | 1 | Apr 25, 2016 | clinicaltrials |
| NCT02643407 | Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer | unknown | Phase 3 | 488 | Guangdong Association of Clinical TrialsOTHER | 1 | Dec 31, 2015 | clinicaltrials |
| NCT02395939 | Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL(CT-CROP) | unknown | Phase 3 | 158 | Middlemore Hospital, New ZealandOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT02481661 | Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC | unknown | Phase 3 | 610 | Zhejiang Cancer HospitalOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | unknown | Phase 2 / Phase 3 | 380 | Bai JunOTHER | 0 | Mar 12, 2015 | clinicaltrials |
| NCT02140333 | Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC | unknown | Phase 3 | 220 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02350361 | Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. | unknown | Phase 2 / Phase 3 | 60 | Peking University Third HospitalOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT02338011 | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)(EGFR) | unknown | Phase 2 / Phase 3 | 210 | Shanghai Chest HospitalOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02283476 | The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. | unknown | Phase 3 | 200 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 6, 2014 | clinicaltrials |
| NCT02281708 | Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma | unknown | Phase 3 | 1,012 | Seoul National University HospitalOTHER | 1 | Nov 3, 2014 | clinicaltrials |
| NCT02058433 | Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 140 | Caicun ZhouOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00030641 | Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | Genta IncorporatedINDUSTRY | 3 | Jan 6, 2014 | clinicaltrials |
| NCT00003447 | Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 3 | 630 | Istituto Nazionale per lo Studio e la Cura dei TumoriOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006048 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006049 | ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003240 | Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | unknown | Phase 3 | 1,800 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00004100 | Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 3 | — | Istituto Nazionale per lo Studio e la Cura dei TumoriOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00022022 | Docetaxel in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | 200 | Istituto Nazionale per lo Studio e la Cura dei TumoriOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00039039 | Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer | unknown | Phase 3 | 300 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT02011997 | Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion(cVATS) | unknown | Phase 3 | 500 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT01287962 | Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer | unknown | Phase 3 | 480 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2013 | clinicaltrials |
| NCT02001896 | Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation | unknown | Phase 3 | 60 | Xinjiang Medical UniversityOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT02001168 | Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB | unknown | Phase 3 | 392 | Xinjiang Medical UniversityOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01980849 | Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer(LCAN) | unknown | Phase 3 | 272 | Shengqing LiOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT01977209 | Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression(GTCA) | unknown | Phase 3 | 204 | Third Military Medical UniversityOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003053 | Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | unknown | Phase 3 | 750 | European Institute of OncologyOTHER | 3 | Sep 20, 2013 | clinicaltrials |
| NCT00004887 | Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | unknown | Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00022009 | Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00055965 | Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin | unknown | Phase 3 | 400 | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01947062 | Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma | unknown | Phase 3 | 60 | Swami Rama Cancer Hospital and Research InstituteINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003696 | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer | unknown | Phase 3 | 250 | Commissie Voor Klinisch Toegepast OnderzoekOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00011921 | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | unknown | Phase 3 | 430 | EBMT Solid Tumors Working PartyOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00112710 | Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 3 | 1,350 | University Hospital BirminghamOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00989690 | Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 3 | 275 | Istituto Scientifico H. San RaffaeleOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00004209 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 3 | — | Cancer Research UKOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00955695 | Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 3 | 242 | National Cancer Center, KoreaOTHER_GOV | 0 | Aug 2, 2013 | clinicaltrials |
| NCT01555710 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | unknown | Phase 3 | 548 | Alaunos TherapeuticsINDUSTRY | 11 | May 21, 2013 | clinicaltrials |
| NCT01802021 | Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients(QSYQT) | unknown | Phase 2 / Phase 3 | 120 | Chang Gung Memorial HospitalOTHER | 1 | Mar 1, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Oct 21, 2016source: clinicaltrials